Fleisch Felix, Reinhart Walter H, Brand Brigit, Berger Christoph
Department of Internal Medicine, Cantonal Hospital, Chur, Switzerland.
Swiss Med Wkly. 2005 Apr 30;135(17-18):263-5. doi: 10.4414/smw.2005.10963.
Immunocompromised patients are at risk of developing Epstein-Barr virus (EBV)-related lymphoproliferative disorders. Quantitative determination of serum EBV DNA permits early diagnosis of an AIDS-related non-Hodgkin's lymphoma, and surveillance of treatment response and/or relapse, and thus may be a useful tool to monitor disease activity.
免疫功能低下的患者有发生与爱泼斯坦-巴尔病毒(EBV)相关的淋巴增殖性疾病的风险。血清EBV DNA的定量测定有助于早期诊断艾滋病相关非霍奇金淋巴瘤,并监测治疗反应和/或复发情况,因此可能是监测疾病活动的有用工具。